Eisai
4523.T
#2489
Rank
โ‚น705.20 B
Marketcap
โ‚น2,500
Share price
-2.03%
Change (1 day)
6.23%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: โ‚น50.17 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น50.17 Billion, an increase over its 2022 earnings that were of -โ‚น2.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023โ‚น50.17 B-2404.04%
2022-โ‚น2.18 Billion-103.6%
2021โ‚น60.54 B-39.81%
2020โ‚น100.58 B7.44%
2019โ‚น93.62 B17.22%
2018โ‚น79.87 B86.16%
2017โ‚น42.90 B-23.52%
2016โ‚น56.10 B26.97%
2015โ‚น44.18 B22.3%
2014โ‚น36.12 B-46.07%
2013โ‚น66.99 B-21.85%
2012โ‚น85.71 B-20.59%
2011โ‚น107.94 B-8.91%
2010โ‚น118.50 B19.21%
2009โ‚น99.41 B